Pan-Asia Index Flows & Special Situations, Quiddity Advisors

Janaghan Jeyakumar, CFA

Equity Analyst with experience in fundamental and event-driven research in Frontier and Emerging markets. 

On Smartkarma, I mainly publish insights on index flow events in the Asia-Pacific region. This includes predicting regular and intra-review index changes and estimating upcoming passive flows. I also cover special situations such as mergers & acquisitions, equity offerings, buybacks, and other corporate restructuring events.

Pan-Asia Index Flows & Special Situations

J.B.Chemicals (JBCP IN): Partial Tender Offer by KKR

Quiddity Advisors

Pan-Asia Catalysts/Events

Event-Driven

On 8th May, India's largest pure-play animal healthcare company <a href="https://www.smartkarma.com/entities/sequent-scientific-ltd" target="_blank" data-smartkarma-citation="entities:18270:1" rel="noopener">Sequent Scientific (SEQ IN)</a>, <a href="https://www.bseindia.com/xml-data/corpfiling/AttachHis/9e7e8ab0-1fd9-4c41-99d1-2526263ab13e.pdf" target="_blank" rel="noopener">announced</a> that The Carlyle Group had entered into binding agreements with promoter shareholders to acquire a majority stake in the company.In accordance with SEBI's takeover regulations, this transaction triggered a mandatory open offer for 26% of total shares. Together, these transactions will allow the Acquirer to increase their stake in the company up to 74% and the Acquirer will become the new promoter of the company. The Deal will be conditional on receiving regulatory approvals and is expected to close in the third quarter of 2020. The Offer price will be INR86.00 per share in cash. Sequent's shares last closed at 82.20.More below the fold.<hr>For more information about Indian M&amp;A, please see <a href="https://www.smartkarma.com/insights/quiddity-india-m-a-guide-2019" target="_blank" data-smartkarma-citation="insights:30885" rel="noopener">Quiddity India M&amp;A Guide 2019</a>.

On 8th May, India's largest pure-play animal healthcare company Sequent Scientific (SEQ IN), announced that The Carlyle Group had entered into binding agreements with promoter shareholders to acquire a majority stake in the company.In accordance with SEBI's takeover regulations, this transaction triggered a mandatory open offer for 26% of total shares. Together, these transactions will allow the Acquirer to increase their stake in the company up to 74% and the Acquirer will become the new promoter of the company. The Deal will be conditional on receiving regulatory approvals and is expected to close in the third quarter of 2020. The Offer price will be INR86.00 per share in cash. Sequent's shares last closed at 82.20.More below the fold.For more information about Indian M&amp;A, please see Quiddity India M&amp;A Guide 2019.

Partial Tender Offer for Sequent Scientific